[ad_1]
Alexandru Rafila stated that he pushed for Remdesivir to be produced in Romania, but things stalled.
“This problem (the production of Remdesivir in Romania) could also be solved in Romania. I personally helped establish a contact with a manufacturing company, several months ago,” said the Romanian representative at WHO on Antena 3.
Then he continued: “The Iaşi Antibiotic Company was interested initially, but, you know how it is, because it is a company with state capital, there must be a political decision, in the end, to support such Approach. Especially since we also have a close relationship with the US and I am convinced that the US embassy, the US government, would have supported such an approach. ”
“Antibiotice Iași does not have financial and decision-making freedom. If we are really interested, we can do this, to support it from the point of view of the Romanian state. I think it is a strategic issue,” concluded Rafila.
The statements of the president of the Romanian Society for Microbiology are framed in the context in which Hungary began to produce domestically the antiviral drug Remdesivir, used to treat COVID-19.
At the same time, in September, the Minister of Health, Nelu Tătaru, said that the production of Remdesivir in Antibiotice Iași is possible, but in a few years, because there is currently no technological line, according to Agerpres.
[ad_2]